Replies to post #39951 on RespireRx Pharmaceuticals Inc (RSPI)

[Investor2014]

Yesterday's FDA Ad Comm 13-0 vote in favour of GW Pharmaceutical's Epidiolox may bode well for RSPI's chances of regulatory progress.